PeptideDB

FTISADTSK

CAS: 1431957-73-1 F: C42H68N10O16 W: 969.05

FTISADTSK is an endogenous stable signature peptide from Trastuzumab monitored by selected reaction monitoring (SRM).
Sales Email：peptidedb@qq.com
Contact QiTai

This product is for research use only, not for human use. We do not sell to patients.

Bioactivity FTISADTSK is an endogenous stable signature peptide from Trastuzumab monitored by selected reaction monitoring (SRM)[1].
Name FTISADTSK
CAS 1431957-73-1
Shortening FTISADTSK
Formula C42H68N10O16
Molar Mass 969.05
Transport Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Biotinyl-Amyloid β-Protein (1-42) (ammonium)

Fmoc-Glu(OtBu)-Thr(psi(Me,Me)pro)-OH

Product Recommendation

Latest release

Hot list

Copyright © 2025 PeptideDB All Rights Reserved

Sitemaps | Contact

Is for research use only, not for human use. We do not sell to patients.